Given that polygenic risk doesn’t change and only needs to be measured once, researchers advocate greater use.

More focus is needed on female-specific barriers to enrollment and completion of programs that can improve their outcomes.

Experts continue to debate whether the health status benefits are real and enough to justify doing the procedures for severe ...

In the recent SOUL trial, the GLP-1 drug reduced the risk of MACE by 14% over 4 years. Next up: a possible obesity indication ...

The “uneven playing field” related to demographics could be smoothed by stroke networks and standardized care.

The results underscore the need to perform CT imaging when deciding between procedures in patients with aortic stenosis.

Elevated lipids increased rates of obstetrical and cardiovascular adverse events over a 5-year follow-up period.

High-profile mistakes have led to a loss in donor confidence. Experts say the system needs modernizing, not abandonment.